Bernardo Bonanni

23.1k total citations · 1 hit paper
189 papers, 5.8k citations indexed

About

Bernardo Bonanni is a scholar working on Genetics, Oncology and Cancer Research. According to data from OpenAlex, Bernardo Bonanni has authored 189 papers receiving a total of 5.8k indexed citations (citations by other indexed papers that have themselves been cited), including 98 papers in Genetics, 77 papers in Oncology and 68 papers in Cancer Research. Recurrent topics in Bernardo Bonanni's work include Estrogen and related hormone effects (67 papers), Breast Cancer Treatment Studies (46 papers) and Cancer Risks and Factors (40 papers). Bernardo Bonanni is often cited by papers focused on Estrogen and related hormone effects (67 papers), Breast Cancer Treatment Studies (46 papers) and Cancer Risks and Factors (40 papers). Bernardo Bonanni collaborates with scholars based in Italy, United States and United Kingdom. Bernardo Bonanni's co-authors include Andrea DeCensi, Massimiliano Cazzaniga, Sara Gandini, Aliana Guerrieri‐Gonzaga, Matteo Puntoni, Harriet Johansson, Alessandra Gennari, Davide Serrano, Matteo Lazzeroni and Pamela J. Goodwin and has published in prestigious journals such as The Lancet, Circulation and Journal of Clinical Oncology.

In The Last Decade

Bernardo Bonanni

176 papers receiving 5.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Metformin and Cancer Risk in Diabetic Patients: A Systematic Review and Meta-analysis

2010 713 citations Andrea DeCensi, Matteo Puntoni et al. Cancer Prevention Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Bernardo Bonanni Italy	38	2.4k	2.3k	2.0k	1.9k	700	189	5.8k
Agnes Jager Netherlands	46	2.5k 1.0×	1.4k 0.6×	1.7k 0.8×	1.1k 0.6×	524 0.7×	227	7.0k
Paul E. Goss Canada	39	2.5k 1.0×	1.6k 0.7×	1.9k 1.0×	3.0k 1.6×	649 0.9×	85	6.2k
Shigehira Saji Japan	39	3.9k 1.6×	2.3k 1.0×	1.8k 0.9×	2.3k 1.2×	676 1.0×	252	7.2k
Andrea DeCensi Italy	51	3.7k 1.5×	4.0k 1.8×	2.5k 1.2×	2.7k 1.4×	670 1.0×	246	9.2k
Francesco Boccardo Italy	39	3.1k 1.3×	1.4k 0.6×	2.3k 1.2×	2.1k 1.2×	606 0.9×	273	6.8k
Hiltrud Brauch Germany	40	2.3k 0.9×	3.4k 1.5×	2.4k 1.2×	1.7k 0.9×	476 0.7×	162	6.8k
Marjanka K. Schmidt Netherlands	42	2.1k 0.9×	1.3k 0.6×	2.0k 1.0×	1.4k 0.8×	596 0.9×	160	4.8k
Christos Markopoulos Greece	33	2.5k 1.0×	1.0k 0.4×	1.7k 0.8×	1.0k 0.5×	569 0.8×	198	4.7k
Samuel Wieand United States	8	2.2k 0.9×	960 0.4×	1.6k 0.8×	2.6k 1.4×	832 1.2×	10	4.9k
Bent Ejlertsen Denmark	44	3.9k 1.6×	1.3k 0.6×	2.8k 1.4×	1.5k 0.8×	754 1.1×	252	6.4k

Countries citing papers authored by Bernardo Bonanni

Since Specialization

Citations

This map shows the geographic impact of Bernardo Bonanni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bernardo Bonanni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bernardo Bonanni more than expected).

Fields of papers citing papers by Bernardo Bonanni

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bernardo Bonanni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bernardo Bonanni. The network helps show where Bernardo Bonanni may publish in the future.

Co-authorship network of co-authors of Bernardo Bonanni

This figure shows the co-authorship network connecting the top 25 collaborators of Bernardo Bonanni. A scholar is included among the top collaborators of Bernardo Bonanni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bernardo Bonanni. Bernardo Bonanni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Serrano, Davide, Cristina Zanzottera, Francesca Fava, et al.. (2025). Hereditary Breast Cancer: Comprehensive Risk Assessment and Prevention Strategies. Genes. 16(1). 82–82. 1 indexed citations

Carbone, Alessio, Martino Oliva, Matteo Puntoni, et al.. (2025). Effect of low-dose tamoxifen on benign gynecological and breast conditions in a phase 3 trial in noninvasive breast cancer. JNCI Journal of the National Cancer Institute.

Fava, Francesca, Monica Marabelli, Mariarosaria Calvello, et al.. (2025). MLH1 promoter hypermethylation and Lynch Syndrome: When to test for constitutional epimutations of MLH1 gene?. Tumori Journal. 3887655698–3887655698. 1 indexed citations

Ruscica, Massimiliano, Chiara Macchi, Sara Gandini, et al.. (2024). Prognostic Value of PCSK9 Levels in Premenopausal Women at Risk of Breast Cancer—Evidence from a 17-Year Follow-Up Study. Cancers. 16(7). 1411–1411.

Serrano, Davide, Federica Bellerba, Harriet Johansson, et al.. (2023). Vitamin D Supplementation and Adherence to World Cancer Research Fund (WCRF) Diet Recommendations for Colorectal Cancer Prevention: A Nested Prospective Cohort Study of a Phase II Randomized Trial. Biomedicines. 11(6). 1766–1766. 3 indexed citations

Corso, Giovanni, Monica Marabelli, Mariarosaria Calvello, et al.. (2023). Germline pathogenic variants in metaplastic breast cancer patients and the emerging role of the BRCA1 gene. European Journal of Human Genetics. 31(11). 1275–1282. 8 indexed citations

Betella, Ilaria, Alessandra Rappa, Davide Vacirca, et al.. (2021). Microsatellite instability evaluation: which test to use for endometrial cancer?. Journal of Clinical Pathology. 76(1). 29–33. 8 indexed citations

Corso, Giovanni, Federica Corso, Federica Bellerba, et al.. (2021). Geographical Distribution of E-cadherin Germline Mutations in the Context of Diffuse Gastric Cancer: A Systematic Review. Cancers. 13(6). 1269–1269. 20 indexed citations

Corso, Giovanni, Francesca Magnoni, Giulia Massari, et al.. (2021). CDH1 germline mutations in healthy individuals from families with the hereditary diffuse gastric cancer syndrome. Journal of Medical Genetics. 59(4). 313–317. 9 indexed citations

10.

Serrano, Davide, Chiara Pozzi, Silvia Guglietta, et al.. (2021). Microbiome as Mediator of Diet on Colorectal Cancer Risk: The Role of Vitamin D, Markers of Inflammation and Adipokines. Nutrients. 13(2). 363–363. 15 indexed citations

11.

Lazzeroni, Matteo, Giovanna Petrangolini, Debora Macis, et al.. (2020). Development of an HPLC-MS/MS Method for the Determination of Silybin in Human Plasma, Urine and Breast Tissue. Molecules. 25(12). 2918–2918. 3 indexed citations

12.

Lazzeroni, Matteo, Andrea DeCensi, Aliana Guerrieri‐Gonzaga, et al.. (2020). Prognostic and predictive value of cell cycle progression (CCP) score in ductal carcinoma in situ of the breast. Modern Pathology. 33(6). 1065–1077. 5 indexed citations

13.

Pravettoni, Gabriella, Alessandra Gorini, Bernardo Bonanni, & Umberto Veronesi. (2016). ecancermedicalscience. ecancermedicalscience. 7. ed26–ed26. 2 indexed citations

14.

DeCensi, Andrea, Matteo Puntoni, Aliana Guerrieri‐Gonzaga, et al.. (2015). Effect of Metformin on Breast Ductal Carcinoma In Situ Proliferation in a Randomized Presurgical Trial. Cancer Prevention Research. 8(10). 888–894. 27 indexed citations

15.

Podo, Franca, Filippo Santoro, Giovanni Di Leo, et al.. (2015). Triple-Negative versus Non–Triple-Negative Breast Cancers in High-Risk Women: Phenotype Features and Survival from the HIBCRIT-1 MRI-Including Screening Study. Clinical Cancer Research. 22(4). 895–904. 24 indexed citations

16.

Curigliano, Giuseppe, Davide Disalvatore, Alessandro Esposito, et al.. (2015). Risk of subsequentin situ and invasive breast cancer in human epidermal growth factor receptor 2-positive ductal carcinomain situ. Annals of Oncology. 26(4). 682–687. 45 indexed citations

17.

Bonanni, Bernardo, Matteo Puntoni, Massimiliano Cazzaniga, et al.. (2012). Dual Effect of Metformin on Breast Cancer Proliferation in a Randomized Presurgical Trial. Journal of Clinical Oncology. 30(21). 2593–2600. 195 indexed citations

18.

DeCensi, Andrea, Matteo Puntoni, Pamela J. Goodwin, et al.. (2010). Metformin and Cancer Risk in Diabetic Patients: A Systematic Review and Meta-analysis. Cancer Prevention Research. 3(11). 1451–1461. 713 indexed citations breakdown →

19.

DeCensi, Andrea, Aliana Guerrieri‐Gonzaga, Sara Gandini, et al.. (2010). Prognostic significance of Ki-67 labeling index after short-term presurgical tamoxifen in women with ER-positive breast cancer. Annals of Oncology. 22(3). 582–587. 59 indexed citations

20.

Johansson, Harriet, Massimiliano Cazzaniga, Bernardo Bonanni, et al.. (2006). Effects of low dose tamoxifen on circulating levels of hormones, C-telopeptide and HER2 extracellular domain in women with primary breast cancer. Cancer Research. 66. 753–753. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact